Credit Agricole’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
RP
BG
Credit Agricole's AMED Position: Q2 2022 in Review
Credit Agricole sold out of Amedisys (AMED) in Q2 2022, closing a stake of 16,620 shares — an estimated $2.86M sold.
Credit Agricole first reported a position in AMED in Q4 2013 and held it in 6 quarters. The position peaked at $4.07M in Q2 2021. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.
- Credit Agricole reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
- Credit Agricole sold 16,620 Amedisys shares in Q2 2022, an estimated $2.86M.
- Credit Agricole first reported a position in Amedisys in Q4 2013 and held it in 6 quarters.
- Credit Agricole's Amedisys position peaked at $4.07M in Q2 2021.
- 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.
Based on Credit Agricole's 13F filing for Q2 2022, filed 8 Aug 2022.